GTBPGT Biopharma, Inc.

Nasdaq gtbiopharma.com


$ 3.13 $ -0.15 (-4.59 %)    

Thursday, 16-May-2024 13:02:37 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 3.12
$ 3.13
$ 0.00 x 0
$ 0.00 x 0
$ 3.13 - $ 3.13
$ 2.95 - $ 16.11
11,867
na
4.31M
$ 0.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 10-31-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-23-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 04-16-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-10-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
39 01-08-2015 12-31-2013 10-K
40 01-08-2015 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 gt-biopharma-q1-eps-164-beats-270-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(1.64) per share which beat the analyst consensus estimate of $(2.70) ...

 recap-gt-biopharma-q4-earnings
Recap: GT Biopharma Q4 Earnings
03/26/2024 21:15:06

 gt-biopharma-q4-eps-214-beats-270-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(2.14) per share which beat the analyst consensus estimate of $(2.70) ...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 gt-biopharma-shares-resume-trade
GT Biopharma Shares Resume Trade
02/05/2024 14:00:33

 gt-biopharma-q3-eps-006-beats-010-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) ...

 hc-wainwright--co-reiterates-buy-on-gt-biopharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

 ef-hutton-reiterates-hold-on-gt-biopharma-maintains-2-price-target

EF Hutton analyst Tony Butler reiterates GT Biopharma (NASDAQ:GTBP) with a Hold and maintains $2 price target.

 gt-biopharma-q2-eps-005-beats-010-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) ...

 why-state-street-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 millio...

 why-aehr-test-systems-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION